Article Investor perspectives Buy, sell or do nothing? Timing is everything May 22, 2020By Oliver Schutzmann
Article Corporate access The week in investor relations: Big polluters brace for shareholder rebellions, drug-makers protect vaccine IP and the ‘culture war’ invades proxy season May 13, 2022By James Beech
Article Investor perspectives The week in investor relations: Active managers underperform, and Unilever nears share unification Oct 16, 2020By Garnet Roach
